Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of Maryland, Baltimore
- Stanford University
- The Ohio State University
- The University of Arizona
- Empa
- Aarhus University
- Ghent University
- Grenoble INP - Institute of Engineering
- HONG KONG BAPTIST UNIVERSITY
- Institute for bioengineering of Catalonia, IBEC
- LIVERPOOL JOHN MOORES UNIVERSITY
- National Institute of Research and Innovation
- Pennsylvania State University
- South Dakota Mines
- Stony Brook University
- UNIVERSIDAD DE ZARAGOZA
- University of Jyväskylä
- University of Miami
- University of Warsaw
- AALTO UNIVERSITY
- Boise State University
- CHU Clermont-Ferrand
- CNRS
- Carnegie Mellon University
- Chalmers University of Technology
- ETH Zürich
- European Synchrotron Radiation Facility
- FAPESP - São Paulo Research Foundation
- Institut Pasteur
- Iowa State University
- Johns Hopkins University
- King's College London
- Koç University
- Laboratory of Oceanography of Villefranche
- Lunds universitet
- Maimonides Biomedical Research Institute of Cordoba - IMIBIC
- Massachusetts Institute of Technology
- Max Planck Institute for Chemistry, Mainz
- Max Planck Institute for Extraterrestrial Physics, Garching
- National Institute of Research and Innovation
- New York University
- Polymer Institute of the Slovak Academy of Sciences
- Rutgers University
- SciLifeLab
- The University of Iowa
- Umeå University
- Universitat Politècnica de Catalunya (UPC)- BarcelonaTECH
- Universitat Rovira i Virgili
- Universite de Montpellier
- University of Florida
- University of Lille
- University of Liverpool
- University of Liverpool;
- University of Lund
- University of Minnesota
- University of North Carolina at Chapel Hill
- University of North Texas at Dallas
- University of Oxford
- University of Texas at Arlington
- Università degli Studi di Trieste
- Universität Duisburg Essen
- Université Côte d'Azur
- Łukasiewicz Research Network - Krakow Institute of Technology
- 53 more »
- « less
-
Field
-
therapy, nanoparticle- or liposome-based targeted delivery, drug-repurposing approaches, or related methodology applicable to oral/head and neck cohorts. Genomic, transcriptomic, or bioinformatic analysis
-
, plasmid, gene editors and nanoparticle transduction of human cells. Preferred Qualifications: Preference will be given to applicants with a demonstrated expertise in developing scientific protocols
-
, such as magnetocaloric materials, permanent magnets, catalysts, magnetic nanoparticles, and molecular spin switches. Your main tasks You will carry out research tasks in Prof. Wende's working group
-
. Experience in evaluating ocular formulations in the animal model of ocular bacterial/viral infections. Experience in various techniques used for the synthesis of nanoparticles, liposomes, nanocrystals
-
using scanning and transmission electron microscopy (SEM and TEM); investigating the release kinetics of active substances from nanoparticles under conditions simulating the target environment; conducting
-
analyze electrochemical oxidation/reduction studies to validate drug-dependent or biomarker-dependent electron transfer and sensor response. • Synthesize and characterize nanoparticles of various
-
characterization of lipid nanoparticles (LNPs) for mRNA delivery is essential. Proficiency in relevant analytical techniques: dynamic light scattering, surface charge measurement and assays for encapsulation/loading
-
immunotherapy interventions targeting CD4+ T cells based on recombinant monoclonal antibodies or mRNA-containing lipid nanoparticles. The project will be primarily developed in a pre-clinical murine model of lung
-
development of new sensors, support nanoparticle-based cellular reprogramming strategies and identify new omics-based biomarkers. We work closely with clinical partners and we focus on deep understanding
-
on developing a microfluidic technology for loading molecules and nanoparticles into red blood cells ex vivo, with the goal of leveraging red blood cells as a biocompatible drug depot for extended release. The